TFF Pharmaceuticals, Inc.
Related Filers (23)
- COLEMAN KIRK ALLEN (15)
- Mattes Glenn R. (12)
- Fletcher Aaron G.L. (12)
- ROCAMBOLI STEPHEN (11)
- Weisman Harlan F (10)
- MILLS ROBERT S (10)
- Lung Therapeutics, Inc. (7)
- THURMAN RANDY H (7)
- WINDSOR JAMES BRIAN (5)
- Fairbairn Malcolm (5)
- CARLSON CAPITAL L P (4)
- Roberts Brandi (4)
- LYTTON LAURENCE W (3)
- Mikhak Zamaneh (3)
- CANO CHRISTOPHER (2)
- Nantahala Capital Management, LLC (2)
- Corriente Advisors, LLC (2)
- Double Black Diamond Offshore Ltd (2)
- Asgard Investment Corp. II (2)
- Carlson Clint Duane (2)
- Patane Michael A (2)
- Lee Catherine Chai-zon (2)
- KING THOMAS BRAXTON (2)
- Show More ...
Financials (19)
10-Q
Tuesday, 11/14/2023
Quarterly Report for period ending 2023-09-30
10-Q
Monday, 8/14/2023
Quarterly Report for period ending 2023-06-30
10-Q
Thursday, 5/11/2023
Quarterly Report for period ending 2023-03-31
10-K
Friday, 3/31/2023
Annual Report for period ending 2022-12-31
10-Q
Monday, 11/14/2022
Quarterly Report for period ending 2022-09-30
10-Q
Thursday, 8/11/2022
Quarterly Report for period ending 2022-06-30
10-Q
Wednesday, 5/11/2022
Quarterly Report for period ending 2022-03-31
10-K
Thursday, 3/24/2022
Annual Report for period ending 2021-12-31
10-Q
Monday, 11/15/2021
Quarterly Report for period ending 2021-09-30
10-Q
Thursday, 8/12/2021
Quarterly Report for period ending 2021-06-30
10-Q
Thursday, 5/13/2021
Quarterly Report for period ending 2021-03-31
10-K/A
Thursday, 4/29/2021
Annual Report for period ending 2020-12-31
10-K
Wednesday, 3/10/2021
Annual Report for period ending 2020-12-31
10-Q
Thursday, 11/5/2020
Quarterly Report for period ending 2020-09-30
10-Q
Thursday, 8/13/2020
Quarterly Report for period ending 2020-06-30
10-Q
Thursday, 5/14/2020
Quarterly Report for period ending 2020-03-31
10-K/A
Wednesday, 4/29/2020
Annual Report for period ending 2019-12-31
10-K
Friday, 3/27/2020
Annual Report for period ending 2019-12-31
10-Q
Monday, 12/9/2019
Quarterly Report for period ending 2019-09-30
News (45)
8-K
Tuesday, 12/19/2023
Current report filing
8-K
Friday, 12/15/2023
Current report filing
8-K
Friday, 12/8/2023
Current report filing
8-K
Monday, 12/4/2023
Current report filing
8-K
Wednesday, 11/22/2023
Current report filing
8-K
Tuesday, 11/14/2023
Current report filing
8-K
Monday, 9/18/2023
Current report filing
8-K
Monday, 9/18/2023
Current report filing
8-K
Tuesday, 8/15/2023
Current report filing
8-K
Friday, 6/23/2023
Current report filing
8-K
Thursday, 5/11/2023
Current report filing
8-K
Thursday, 4/6/2023
Current report filing
8-K
Wednesday, 3/8/2023
Current report filing
8-K
Tuesday, 3/7/2023
Current report filing
8-K
Friday, 2/17/2023
Current report filing
8-K
Thursday, 2/16/2023
Current report filing
8-K
Thursday, 2/9/2023
Current report filing
8-K
Wednesday, 1/11/2023
Current report filing
8-K
Thursday, 12/8/2022
Current report filing
8-K
Friday, 11/18/2022
Current report filing
8-K
Monday, 11/14/2022
Current report filing
8-K
Tuesday, 11/8/2022
Current report filing
8-K
Friday, 9/30/2022
Current report filing
8-K
Thursday, 8/11/2022
Current report filing
8-K
Friday, 6/10/2022
Current report filing
8-K
Wednesday, 5/11/2022
Current report filing
8-K
Thursday, 3/24/2022
Current report filing
8-K
Tuesday, 12/21/2021
Current report filing
8-K
Tuesday, 11/16/2021
Current report filing
8-K
Wednesday, 11/10/2021
Current report filing
8-K
Thursday, 8/12/2021
Current report filing
8-K
Thursday, 5/13/2021
Current report filing
8-K
Friday, 3/26/2021
Current report filing
8-K
Wednesday, 3/10/2021
Current report filing
8-K
Friday, 12/4/2020
Current report filing
8-K
Friday, 12/4/2020
Current report filing
8-K
Thursday, 11/5/2020
Current report filing
8-K
Thursday, 10/1/2020
Current report filing
8-K
Wednesday, 9/30/2020
Current report filing
8-K
Thursday, 8/13/2020
Current report filing
8-K
Tuesday, 8/11/2020
Current report filing
8-K
Thursday, 5/14/2020
Current report filing
8-K
Thursday, 3/26/2020
Current report filing
8-K
Friday, 1/31/2020
Current report filing
8-K
Tuesday, 12/17/2019
Current report filing
Other (17)
EFFECT
Tuesday, 12/12/2023
Notice of Effectiveness
CORRESP
Friday, 12/8/2023
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
ARS
Wednesday, 10/4/2023
Annual report to security holders
EFFECT
Monday, 11/23/2020
Notice of Effectiveness
CORRESP
Thursday, 11/19/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
EFFECT
Tuesday, 9/15/2020
Notice of Effectiveness
CORRESP
Friday, 9/11/2020
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Wednesday, 8/19/2020
Exempt (Private) Offering
EFFECT
Thursday, 10/24/2019
Notice of Effectiveness
CERT
Wednesday, 10/23/2019
Certification by an exchange approving securities for listing
8-A12B
Tuesday, 10/22/2019
Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
CORRESP
Tuesday, 10/22/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 10/22/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Friday, 9/27/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
CORRESP
Tuesday, 8/20/2019
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
D
Wednesday, 7/24/2019
Exempt (Private) Offering
D
Tuesday, 3/27/2018
Exempt (Private) Offering
Ownership (120)
SC 13G/A
Wednesday, 2/14/2024
LYTTON LAURENCE W: Major Shareholders
4
Friday, 12/15/2023
KING THOMAS BRAXTON: Statement of changes in beneficial ownership of securities
3
Friday, 12/15/2023
KING THOMAS BRAXTON: Initial statement of beneficial ownership of securities
4
Monday, 12/4/2023
ROCAMBOLI STEPHEN: Statement of changes in beneficial ownership of securities
3
Monday, 12/4/2023
Patane Michael A: Initial statement of beneficial ownership of securities
4
Monday, 12/4/2023
MILLS ROBERT S: Statement of changes in beneficial ownership of securities
3
Monday, 12/4/2023
Lee Catherine Chai-zon: Initial statement of beneficial ownership of securities
4
Monday, 12/4/2023
Roberts Brandi: Statement of changes in beneficial ownership of securities
4
Monday, 12/4/2023
Lee Catherine Chai-zon: Statement of changes in beneficial ownership of securities
4
Monday, 12/4/2023
Patane Michael A: Statement of changes in beneficial ownership of securities
3
Thursday, 8/17/2023
CARLSON CAPITAL L P: Initial statement of beneficial ownership of securities
4
Thursday, 8/17/2023
CARLSON CAPITAL L P: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Weisman Harlan F: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Roberts Brandi: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
ROCAMBOLI STEPHEN: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
Mikhak Zamaneh: Statement of changes in beneficial ownership of securities
4
Tuesday, 8/15/2023
MILLS ROBERT S: Statement of changes in beneficial ownership of securities
4
Friday, 3/24/2023
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Monday, 3/13/2023
Mikhak Zamaneh: Statement of changes in beneficial ownership of securities
4
Monday, 3/13/2023
Weisman Harlan F: Statement of changes in beneficial ownership of securities
4
Monday, 3/13/2023
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Monday, 3/13/2023
ROCAMBOLI STEPHEN: Statement of changes in beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Lung Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/13/2023
LYTTON LAURENCE W: Major Shareholders
SC 13G/A
Thursday, 2/9/2023
CARLSON CAPITAL L P: Major Shareholders
3
Friday, 1/20/2023
Mikhak Zamaneh: Initial statement of beneficial ownership of securities
4
Friday, 12/30/2022
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Friday, 12/30/2022
Roberts Brandi: Statement of changes in beneficial ownership of securities
4
Friday, 12/30/2022
MILLS ROBERT S: Statement of changes in beneficial ownership of securities
4
Friday, 12/30/2022
ROCAMBOLI STEPHEN: Statement of changes in beneficial ownership of securities
4
Monday, 12/19/2022
Weisman Harlan F: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/6/2022
Weisman Harlan F: Statement of changes in beneficial ownership of securities
SC 13G
Monday, 11/28/2022
CARLSON CAPITAL L P: Major Shareholders
SC 13G
Wednesday, 11/23/2022
LYTTON LAURENCE W: Major Shareholders
4
Wednesday, 11/23/2022
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Friday, 9/30/2022
THURMAN RANDY H: Statement of changes in beneficial ownership of securities
4
Friday, 5/20/2022
Weisman Harlan F: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/17/2022
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/17/2022
ROCAMBOLI STEPHEN: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/17/2022
Weisman Harlan F: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/17/2022
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/17/2022
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Monday, 4/4/2022
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
3
Monday, 4/4/2022
Roberts Brandi: Initial statement of beneficial ownership of securities
SC 13G/A
Monday, 2/14/2022
Corriente Advisors, LLC: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Lung Therapeutics, Inc.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Nantahala Capital Management, LLC: Major Shareholders
4
Friday, 9/24/2021
CANO CHRISTOPHER: Statement of changes in beneficial ownership of securities
4
Thursday, 9/16/2021
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Thursday, 9/16/2021
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/19/2021
Fairbairn Malcolm: Statement of changes in beneficial ownership of securities
4
Wednesday, 5/19/2021
THURMAN RANDY H: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/30/2021
Lung Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/17/2021
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/17/2021
ROCAMBOLI STEPHEN: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/17/2021
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/18/2021
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
SC 13G
Tuesday, 2/16/2021
Nantahala Capital Management, LLC: Major Shareholders
SC 13G
Tuesday, 2/16/2021
Corriente Advisors, LLC: Major Shareholders
4
Friday, 2/12/2021
MILLS ROBERT S: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/3/2021
Lung Therapeutics, Inc.: Major Shareholders
4
Wednesday, 1/20/2021
MILLS ROBERT S: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/20/2021
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/20/2021
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/29/2020
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/29/2020
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/15/2020
MILLS ROBERT S: Statement of changes in beneficial ownership of securities
4
Wednesday, 12/9/2020
WINDSOR JAMES BRIAN: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/8/2020
Lung Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/24/2020
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
ROCAMBOLI STEPHEN: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
THURMAN RANDY H: Statement of changes in beneficial ownership of securities
4
Friday, 11/13/2020
Fairbairn Malcolm: Statement of changes in beneficial ownership of securities
3
Tuesday, 9/29/2020
CANO CHRISTOPHER: Initial statement of beneficial ownership of securities
4
Wednesday, 8/26/2020
WINDSOR JAMES BRIAN: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/26/2020
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/26/2020
THURMAN RANDY H: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/26/2020
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/26/2020
ROCAMBOLI STEPHEN: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/26/2020
MILLS ROBERT S: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/26/2020
Weisman Harlan F: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/26/2020
Fairbairn Malcolm: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/26/2020
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/26/2020
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Friday, 4/17/2020
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Monday, 4/6/2020
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Wednesday, 2/19/2020
Fairbairn Malcolm: Statement of changes in beneficial ownership of securities
3
Wednesday, 2/5/2020
Fairbairn Malcolm: Initial statement of beneficial ownership of securities
SC 13G
Monday, 2/3/2020
Lung Therapeutics, Inc.: Major Shareholders
4
Thursday, 12/26/2019
COLEMAN KIRK ALLEN: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/3/2019
Weisman Harlan F: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/3/2019
MILLS ROBERT S: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/3/2019
Fletcher Aaron G.L.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/3/2019
Mattes Glenn R.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/3/2019
WINDSOR JAMES BRIAN: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/3/2019
THURMAN RANDY H: Statement of changes in beneficial ownership of securities
Prospectus (27)
S-3/A
Friday, 12/8/2023
Registration statement for specified transactions by certain issuers
S-3
Tuesday, 11/21/2023
Registration statement for specified transactions by certain issuers
424B5
Wednesday, 8/16/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 8/14/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 6/27/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 6/23/2023
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 11/18/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Thursday, 11/17/2022
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 6/10/2022
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Monday, 12/27/2021
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Monday, 3/29/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 3/26/2021
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 12/8/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Friday, 12/4/2020
Prospectus filed pursuant to Rule 424(b)(5)
S-3/A
Thursday, 11/19/2020
Registration statement for specified transactions by certain issuers
S-3
Thursday, 11/5/2020
Registration statement for specified transactions by certain issuers
S-8
Wednesday, 10/7/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
S-1
Wednesday, 9/9/2020
General form of registration statement for all companies including face-amount certificate companies
424B4
Friday, 10/25/2019
Prospectus filed pursuant to Rule 424(b)(4)
S-1/A
Friday, 10/11/2019
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Friday, 10/4/2019
General form of registration statement for all companies including face-amount certificate companies
S-1/A
Friday, 9/27/2019
General form of registration statement for all companies including face-amount certificate companies
FWP
Friday, 8/23/2019
Filing under Securities Act Rules 163/433 of free writing prospectuses
S-1
Tuesday, 8/20/2019
General form of registration statement for all companies including face-amount certificate companies
DRS/A
Wednesday, 7/17/2019
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Wednesday, 7/17/2019
Correspondence Related to Draft Registration Statement
DRS
Thursday, 10/11/2018
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Proxies (9)
DEF 14A
Wednesday, 10/4/2023
Definitive proxy statements
DEFA14A
Wednesday, 10/4/2023
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
PRE 14A
Friday, 9/22/2023
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEF 14A
Tuesday, 12/27/2022
Definitive proxy statements
PRE 14A
Thursday, 12/15/2022
Preliminary proxy statement not related to a contested matter or merger/acquisition
DEFA14A
Thursday, 10/6/2022
Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
DEF 14A
Wednesday, 9/21/2022
Definitive proxy statements
DEF 14A
Thursday, 9/23/2021
Definitive proxy statements
DEF 14A
Friday, 8/28/2020
Definitive proxy statements